PAST PRESIDENT, CEO AND CHAIRMAN OF THE HERSHEY COMPANY JOINS HEMP
INDUSTRY LEADER, FOLIUM BIOSCIENCES, ON BOARD OF DIRECTORS
February 25, 2019
Colorado Springs, CO – As the 2018 Farm Bill awaits being signed into law by the White House, Folium Biosciences, the largest vertically-integrated producer, manufacturer, and distributor of hemp-derived phytocannabinoids (CBD), announced the first outside member of its board of directors: John P. Bilbrey, the immediate past President, CEO and Chairman of The Hershey Company. Mr. Bilbrey was instrumental in the growth of some of the world’s largest and best-known brands during his career with Procter & Gamble, Danone Waters and the Hershey Company. Bilbrey also currently serves on the Board of Directors of Colgate Palmolive Company and as an advisory board member to the Royal Bank of Canada.
Kashif Shan, Folium Biosciences’ CEO, issued the following statement about the Farm Bill’s significance for the hemp industry and Bilbrey’s participation on the board:
“Our markets are already large, and with the unambiguous legitimization of hemp in the Farm Bill, they’re primed to grow enormously. We expect to see a rapid penetration of mainstream food, beverage and cosmeceutical markets as soon as the Farm Bill passes. For that reason, J.P. Bilbrey’s arrival couldn’t be more timely. His unique combination of strategic thinking, creativity and strong operational skills, along with nearly 4 decades of consumer goods experience, will prove an invaluable asset to Folium Biosciences.”
J.P. Bilbrey understands the impact of removing hemp-derived products from the list of Schedule 1 substances:
“With the passing of the Farm Bill, CBD will finally be legalized and has remarkable growth potential. I believe Folium Biosciences is a forward-thinking industry leader, which excels in research, product development, and innovation. It is meeting consumer needs across a broad range of high quality products.”
“This is an exciting time and I look forward to being involved with this significant growth opportunity,” Bilbrey added.
About Folium Biosciences:
Folium Biosciences is the largest vertically-integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in the USA, if not the world. It is a B2B, bulk and wholesale supplier of hemp derived CBD 0.0% THC oil, CBD water soluble technology, CBD 0.0% THC edibles, and CBD for animal health as certified by the state of Colorado.
Folium Biosciences supplies its unique 0.0% THC phytocannabinoid-rich hemp oil to diverse industries, including the supplement, cosmetic, personal care, and animal health industries. This Colorado Springs company has grown to become the global leader in non-psychoactive cannabinoids and employs in excess of 200 people.
Folium Biosciences has over 300K-square-feet of indoor space in southern Colorado which supports agricultural intake, processing, extraction, and post extraction operations. Folium Biosciences is also proud to announce the forthcoming launch of its new pharmaceutical division, including joint venture partnerships with hospitals, healthcare teaching facilities and universities. It will be engaging in clinical and pharmacology studies both domestically and internationally. 2019 will also see the finished construction of Folium Biosciences’ new Canadian facility, along, hopefully, with licensing throughout the Queen’s commonwealth.
Folium Biosciences ships its 0.0% THC white label, bulk and finished products to customers world-wide. Why can Folium Biosciences claim 0.0% THC?
Folium Biosciences’ chromatographic purification process has been able to selectively remove the only psychoactive component, Delta 9-THC, from the phytocannabinoid-rich hemp oil. The absence of detectable THC is confirmed through High Performance Liquid Chromatography (HPLC) tests. Folium Biosciences has been certified by the CDPHE (Colorado Department of Public Health and Environment) as a producer of 0.0% THC products and has been issued Free Sale Certification.